The foremost producer and evaluator of the healthcare evidence base, serving local, regional, national, and international partners of the university as well as healthcare providers across the globe. Our focus is on optimizing pharmacotherapy in underserved populations.
An international hub for innovation that brings together scientific disciplines in a nontraditional approach.
A centralized office charged with administrative oversight for all clinical research activities of the university's faculty members. The CRO facilitates compliant, meaningful research within the institution by unifying policies governing research conduct across all university schools and departments.
Our laboratory is focused on novel approaches to combat bacterial resistance by studying interdisciplinary areas including antimicrobial pharmacokinetics and pharmacodynamics, clinical pharmacology, bacterial genetics, and translational medicine. We utilize a variety approaches to optimize the profile of new and existing antibiotics including susceptibility and bactericidal testing, the cutting edge hollow fiber infection model, and advanced pharmacometric analysis.
This program focuses on understanding the relationship between the pharmacokinetics of immunosuppressive drugs, pharmacodynamics of immunologic markers, and pharmacogenomic endpoints as related to race and gender of renal transplant recipients.
A collaborative hub for the School of Pharmacy and Pharmaceutical Sciences faculty that are interested in clinical and translational pharmacotherapy research activities.
A postgraduate fellowship training initiative with an emphasis on HIV/AIDS clinical pharmacology between the University at Buffalo (UB) and the University of Zimbabwe (UZ). Program faculty at both institutions contribute mentored training to UZ students and scholars who, in turn, will contribute clinical pharmacology expertise to multidisciplinary teams to achieve the HIV/AIDS research goals for Zimbabwe.